AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.
Clinical studies remain one of the most difficult phases in medical device development. They’re slow, expensive, and sometimes unpredictable — but completely necessary for nearly everything that ...
Innovations in clinical trial designs and tools have the potential to unlock a new era of research that is more convenient for patients, more reflective of real-world treatment conditions, and more ...
New sites expected to further accelerate patient enrollment, which surpassed 50% in Phase III study, as well as support ...
~ No serious adverse events and 92% reduction in seizure frequency observed in the first trial participant through first five months of follow up ~ ~ Data to be presented today at Epilepsy Therapies & ...
Representative clinical studies are important as diseases and medicines can affect people differently depending on their age, sex, and race and ethnicity. According to the Food and Drug Administration ...
Xenon Pharmaceuticals provided an update on its pipeline programs, highlighting significant progress and upcoming milestones for 2025. The company anticipates topline data from its first Phase 3 study ...
Surveys show that a lot of people don’t have much information about clinical trials. Here's what you need to know about clinical trial costs.
Many times, when people think about joining clinical trials, getting a doctor’s referral is the first thing that comes to mind. Interestingly, that’s not necessarily the case. Unless stated otherwise, ...
Industry sponsors will be required to submit diversity action plans for certain key clinical studies of drugs and devices, according to draft guidance released recently by the US Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results